Processa Pharmaceuticals, Inc. Research and Development Expense
Processa Pharmaceuticals, Inc. (PCSA) reported Research and Development Expense of $5.80 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-03-29
- Processa Pharmaceuticals, Inc. research and development expense for the quarter ending 2022-03-31 was $2.04M, a 38.47% increase year-over-year.
- Processa Pharmaceuticals, Inc. research and development expense for the quarter ending 2021-03-31 was $1.48M, a 194.19% increase year-over-year.
- Processa Pharmaceuticals, Inc. research and development expense for the quarter ending 2020-12-31 was $1.71M, a 231.32% increase year-over-year.
- Processa Pharmaceuticals, Inc. research and development expense for the quarter ending 2020-09-30 was $532.59K, a 8.96% decline year-over-year.
- Processa Pharmaceuticals, Inc. research and development expense for fiscal 2023 was $5.80M, a 49.54% decline from fiscal 2022.
- Processa Pharmaceuticals, Inc. research and development expense for fiscal 2022 was $11.49M, a 67.12% increase from fiscal 2021.
- Processa Pharmaceuticals, Inc. research and development expense for fiscal 2021 was $6.88M, a 116.81% increase from fiscal 2020.
- Processa Pharmaceuticals, Inc. research and development expense for fiscal 2020 was $3.17M, a 36.71% increase from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 27 month | Research and Development Expense 30 month | Research and Development Expense 33 month | Research and Development Expense 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $5.80M 10-K · filed 2024-03-29 | |||||||||||
| 2022-12-31 | $11.49M 10-K · filed 2024-03-29 | |||||||||||
| 2022-03-31 | $2.04M 10-Q · filed 2022-05-12 | |||||||||||
| 2021-12-31 | $6.88M 10-K · filed 2023-03-30 | |||||||||||
| 2021-03-31 | $1.48M 10-Q · filed 2022-05-12 | $3.19M derived: sum of 2 quarters · filed 2022-05-12 | $3.72M derived: sum of 3 quarters · filed 2022-05-12 | $4.15M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||
| 2020-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $2.24M derived: sum of 2 quarters · filed 2022-03-30 | $2.67M derived: sum of 3 quarters · filed 2022-03-30 | $3.17M 10-K · filed 2022-03-30 | ||||||||
| 2020-09-30 | $532.59K 10-Q · filed 2020-11-12 | $959.70K derived: sum of 2 quarters · filed 2020-11-12 | $1.46M 10-Q · filed 2020-11-12 | $1.98M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||
| 2020-06-30 | $427.11K 10-Q · filed 2020-08-05 | $925.86K 10-Q · filed 2020-08-05 | $1.45M derived: sum of 3 quarters · filed 2021-05-13 | $2.03M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||
| 2020-03-31 | $501.77K 10-Q · filed 2021-05-13 | $1.02M derived: sum of 2 quarters · filed 2021-05-13 | $1.60M derived: sum of 3 quarters · filed 2021-05-13 | $2.33M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||
| 2019-12-31 | $516.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $1.10M derived: sum of 2 quarters · filed 2021-03-25 | $1.83M derived: sum of 3 quarters · filed 2021-03-25 | $2.32M 10-K · filed 2021-03-25 | ||||||||
| 2019-09-30 | $584.98K 10-Q · filed 2020-11-12 | $1.31M derived: sum of 2 quarters · filed 2020-11-12 | $1.80M 10-Q · filed 2020-11-12 | $2.40M derived: sum of 4 quarters · filed 2020-11-12 | ||||||||
| 2019-06-30 | $726.90K 10-Q · filed 2020-08-05 | $1.21M 10-Q · filed 2020-08-05 | $1.82M derived: sum of 3 quarters · filed 2020-08-05 | $2.43M derived: sum of 4 quarters · filed 2020-08-05 | ||||||||
| 2019-03-31 | $484.75K 10-Q · filed 2020-05-15 | $1.09M derived: sum of 2 quarters · filed 2020-05-15 | $1.70M derived: sum of 3 quarters · filed 2020-05-15 | $2.78M derived: sum of 4 quarters · filed 2020-05-15 | ||||||||
| 2018-12-31 | $607.84K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $1.22M derived: sum of 2 quarters · filed 2020-03-06 | $2.30M derived: sum of 3 quarters · filed 2020-03-06 | $3.09M 10-K · filed 2020-03-06 | ||||||||
| 2018-09-30 | $611.61K 10-Q · filed 2019-11-14 | $1.69M derived: sum of 2 quarters · filed 2019-11-14 | $2.48M 10-Q · filed 2019-11-14 | $2.70M derived: sum of 4 quarters · filed 2019-11-14 | ||||||||
| 2018-06-30 | $1.08M 10-Q · filed 2019-08-14 | $1.87M 10-Q · filed 2019-08-14 | $2.09M derived: sum of 3 quarters · filed 2019-08-14 | $2.55M derived: sum of 4 quarters · filed 2019-08-14 | ||||||||
| 2018-03-31 | $821.39K 10-Q · filed 2019-05-14 | $807.66K 10-Q · filed 2018-05-21 | $1.01M derived: sum of 2 quarters · filed 2019-05-14 | $1.47M derived: sum of 3 quarters · filed 2019-05-14 | $1.63M derived: sum of 4 quarters · filed 2019-05-14 | |||||||
| 2017-12-31 | $191.63K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | $649.26K derived: sum of 2 quarters · filed 2019-04-08 | $810.13K derived: sum of 3 quarters · filed 2019-04-08 | $964.16K 10-K/A · filed 2019-04-08 | $926.12K 10-K · filed 2018-04-16 | |||||||
| 2017-09-30 | $457.63K 10-Q · filed 2018-11-14 | $618.50K derived: sum of 2 quarters · filed 2018-11-14 | $772.53K 10-Q · filed 2018-11-14 | $166.00 10-Q · filed 2017-11-20 | $2.29M derived: sum of 4 quarters · filed 2018-11-14 | |||||||
| 2017-06-30 | $160.87K 10-Q · filed 2018-08-14 | $83.00 10-Q · filed 2017-10-04 | $311.16K 10-Q · filed 2018-08-14 | $166.00 10-Q · filed 2017-10-04 | $1.83M derived: sum of 3 quarters · filed 2018-08-14 | $1.83M derived: sum of 4 quarters · filed 2018-08-14 | ||||||
| 2017-03-31 | $139.92K 10-Q · filed 2018-05-21 | $83.00 10-Q · filed 2017-10-04 | $1.67M derived: sum of 2 quarters · filed 2018-05-21 | $1.67M derived: sum of 3 quarters · filed 2018-05-21 | $1.68M derived: sum of 4 quarters · filed 2018-05-21 | |||||||
| 2016-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-16 | $1.53M derived: sum of 2 quarters · filed 2018-04-16 | $1.54M derived: sum of 3 quarters · filed 2018-04-16 | $1.54M 10-K · filed 2018-04-16 | $6.56K 10-K · filed 2017-09-25 | |||||||
| 2016-09-30 | $574.00 10-Q · filed 2017-11-20 | $6.27K derived: sum of 2 quarters · filed 2017-11-20 | $6.27K 10-Q · filed 2017-11-20 | |||||||||
| 2016-06-30 | $5.70K 10-Q · filed 2017-10-04 | $5.70K 10-Q · filed 2017-10-04 | ||||||||||
| 2015-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $6.71K derived: sum of 2 quarters · filed 2017-09-25 | $17.51K derived: sum of 3 quarters · filed 2017-09-25 | $29.25K 10-K · filed 2017-09-25 | ||||||||
| 2015-09-30 | $1.71K 10-Q · filed 2017-09-08 | $12.51K derived: sum of 2 quarters · filed 2017-09-08 | $24.25K 10-Q · filed 2017-09-08 | $27.15K 10-Q · filed 2015-12-01 | $22.34K derived: sum of 4 quarters · filed 2017-09-08 | |||||||
| 2015-06-30 | $10.79K 10-Q · filed 2017-08-30 | $10.98K 10-Q · filed 2015-08-19 | $22.53K 10-Q · filed 2017-08-30 | $25.43K 10-Q · filed 2015-08-19 | $20.62K derived: sum of 3 quarters · filed 2017-08-30 | $32.35K derived: sum of 4 quarters · filed 2017-08-30 | ||||||
| 2015-03-31 | $11.74K 10-Q · filed 2017-08-07 | $14.45K 10-Q · filed 2015-05-15 | $9.83K derived: sum of 2 quarters · filed 2017-08-07 | $21.56K derived: sum of 3 quarters · filed 2017-08-07 | $90.05K derived: sum of 4 quarters · filed 2017-08-07 | |||||||
| 2014-12-31 | -$1.91K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $9.82K derived: sum of 2 quarters · filed 2017-06-19 | $78.32K derived: sum of 3 quarters · filed 2017-06-19 | $178.09K 10-K · filed 2017-06-19 | $189.75K 10-K · filed 2015-04-14 | |||||||
| 2014-09-30 | $11.73K 10-Q · filed 2015-12-01 | $80.22K derived: sum of 2 quarters · filed 2015-12-01 | $179.99K 10-Q · filed 2015-12-01 | $256.60K derived: sum of 4 quarters · filed 2015-12-01 | ||||||||
| 2014-06-30 | $68.50K 10-Q · filed 2015-08-19 | $168.26K 10-Q · filed 2015-08-19 | $244.88K derived: sum of 3 quarters · filed 2015-08-19 | $300.34K derived: sum of 4 quarters · filed 2015-08-19 | ||||||||
| 2014-03-31 | $99.77K 10-Q · filed 2015-05-15 | $176.38K derived: sum of 2 quarters · filed 2015-05-15 | $231.84K derived: sum of 3 quarters · filed 2015-05-15 | $295.20K derived: sum of 4 quarters · filed 2015-05-15 | $988.64K 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | $76.61K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $132.08K derived: sum of 2 quarters · filed 2015-04-14 | $195.44K derived: sum of 3 quarters · filed 2015-04-14 | $267.06K 10-K · filed 2015-04-14 | $888.87K 10-K · filed 2014-03-27 | |||||||
| 2013-09-30 | $55.47K 10-Q · filed 2014-11-13 | $118.83K derived: sum of 2 quarters · filed 2014-11-13 | $190.45K 10-Q · filed 2014-11-13 | $282.27K derived: sum of 4 quarters · filed 2014-11-13 | $812.26K 10-Q · filed 2013-11-08 | |||||||
| 2013-06-30 | $63.36K 10-Q · filed 2014-08-19 | $134.99K 10-Q · filed 2014-08-19 | $226.80K derived: sum of 3 quarters · filed 2014-08-19 | $290.87K derived: sum of 4 quarters · filed 2014-08-19 | $756.79K 10-Q/A · filed 2013-09-06 | |||||||
| 2013-03-31 | $71.63K 10-Q · filed 2014-05-14 | $163.44K derived: sum of 2 quarters · filed 2014-05-14 | $227.51K derived: sum of 3 quarters · filed 2014-05-14 | $375.56K derived: sum of 4 quarters · filed 2014-05-14 | ||||||||
| 2012-12-31 | $91.82K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $155.89K derived: sum of 2 quarters · filed 2014-03-27 | $303.93K derived: sum of 3 quarters · filed 2014-03-27 | $448.03K 10-K · filed 2014-03-27 | ||||||||
| 2012-09-30 | $64.07K 10-Q · filed 2013-11-08 | $212.11K derived: sum of 2 quarters · filed 2013-11-08 | $356.21K 10-Q · filed 2013-11-08 | |||||||||
| 2012-06-30 | $148.04K 10-Q/A · filed 2013-09-06 | $292.14K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |